The Latest Breaking News from Meridian

15g will instantly lift your mood as much as a bedtime hug

NZ’s largest hydro power station wrestles with a nationally significant river

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

A Ukrainian cargo plane carrying munitions from Serbia to Bangladesh crashed in northern Greece late on Saturday, killing all eight crew members on board, Greek and Serbian authorities said on Sunday.

These are the final Bushnell/Golfweek Coaches Polls of 2022 for men's golf in NJCAA Div. I and Div. II.

Meridian Bioscience Inc (NASDAQ:VIVO) reported a 30% increase in Q2 sales to $111.2 million, the highest in the company's history, with both segments ahead of expectations, beating the consensus of $99.54 million. Revenues from the life science division grew 32% Y/Y to $70.1 million. Diagnostic segment sales rose 29% to $41.1 million.…

The Government has dramatically cut back the annual allocation of free carbon credits to the Tiwai Point aluminium smelter.

By raising the possibility of staying past 2024, Rio Tinto has thrown a wrench of uncertainty into decarbonisation pathways and power company construction plans.

  Meridian (NASDAQ:MRBK) reported its Q4 earnings results on Monday, January 31, 2022 at 03:41 PM. Here's what investors need to know about the announcement.